Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Disbacteriosis

moxifloxacin has been researched along with Disbacteriosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dartois, V; Mittereder, LR; Namasivayam, S; Oland, S; Sher, A; Wang, H; Zimmerman, M1
Andremont, A; Burdet, C; Corbel, T; de Gunzburg, J; Ferreira, S; Hugon, P; Mentré, F; Nguyen, TT; Pulse, M; Sablier-Gallis, F; Saint-Lu, N; Sayah-Jeanne, S; Weiss, W1

Other Studies

2 other study(ies) available for moxifloxacin and Disbacteriosis

ArticleYear
The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability.
    mBio, 2023, 04-25, Volume: 14, Issue:2

    Topics: Animals; Antitubercular Agents; Biological Availability; Dysbiosis; Humans; Isoniazid; Mice; Moxifloxacin; Pyrazinamide; Rifampin; Tuberculosis

2023
Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Cricetinae; Dysbiosis; Gastrointestinal Microbiome; Male; Mesocricetus; Moxifloxacin

2018